Merck Settles Investor Suits Over Cholesterol Drug
Friday, February 15, 2013 - 01:30
in Health & Medicine
The drug maker agreed to pay $688 million to settle two lawsuits that said it had harmed investors by delaying the release of unfavorable study results for a cholesterol drug.